Gut Microbes Could Play a Protective Role Against Chemotherapy Side Effects
Emerging research suggests gut bacteria can reduce chemotherapy side effects, potentially leading to probiotic-based treatments to improve cancer therapy tolerability.
Recent research from the University of California, San Francisco, indicates that gut microbiota may have a significant impact on how patients tolerate chemotherapy treatments. Chemotherapy, essential for cancer treatment, is known to disrupt the natural balance of microbes in the digestive system, often leading to side effects such as nausea, vomiting, and nerve discomfort. However, scientists have discovered that certain bacteria in the gut can help mitigate these adverse effects.
The study focused on colorectal cancer patients undergoing treatment with fluoropyrimidine drugs. Findings revealed that individuals with less diverse gut microbiomes experienced fewer beneficial bacteria capable of breaking down chemotherapy drugs into harmless byproducts. These bacteria essentially act as biological agents that can absorb and chemically modify chemotherapy agents, reducing their toxicity.
Furthermore, researchers observed that measuring specific bacterial populations could predict the severity of side effects. Mice experiments demonstrated that introducing these beneficial microbes improved symptoms of severe chemotherapy toxicity, suggesting potential for probiotic therapies in humans.
A second related study uncovered that some gut bacteria produce vitamin K2, a compound linked to the protection against nerve-related side effects such as numbness and tingling. Patients with higher levels of these bacteria, especially nonpathogenic E. coli strains, reported fewer side effects. Administration of vitamin K2 to mice further supported its role in alleviating chemotherapy-induced discomfort.
This research highlights the critical relationship between the gut microbiome and drug toxicity. Better understanding might lead to new strategies for managing chemotherapy side effects, including targeted probiotics or microbiome modulation. Such approaches could improve treatment outcomes and quality of life for cancer patients.
Source: https://medicalxpress.com/news/2025-05-gut-microbes-patients-chemotherapy-side.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Breast Cancer Survival and Its Link to Reduced Alzheimer's Risk: The Role of Radiation Therapy
Breast cancer survivors may experience a short-term reduction in Alzheimer's disease risk, especially with radiation therapy. New research highlights the impact of treatment on cognitive health in long-term cancer survivorship.
Promising Results from Shortened Immunotherapy Duration for Advanced Melanoma in Clinical Trial
A groundbreaking clinical trial suggests that stopping immunotherapy after one year may be as effective as two years for advanced melanoma, potentially reducing side effects and treatment burden.
Innovative Method for Measuring Aging Speeds Enhances Understanding of Healthspan and Lifespan in Older Adults
A new method for measuring the Pace of Aging improves prediction of health risks and enhances understanding of aging trajectories in older adults, supporting better health interventions and policies.
Innovative Nerve Stimulation Trial Shows Promising Results for Spinal Cord Injury Recovery
A groundbreaking clinical trial demonstrates that closed-loop vagus nerve stimulation combined with rehabilitation significantly improves arm and hand functions in individuals with spinal cord injuries, showing promising potential for FDA approval and future treatments.